New Platinum Drug Kills Cancer Cells Better
7/17/2012
Researchers at Massachusetts Institute of Technology (MIT) in the US who are testing phenanthriplatin, a new experimental drug based on platinum, say it kills cancer cells better and may provide a more effective alternative to cisplatin, the most commonly used approved platinum chemotherapy drug...
What Is Plavix (Clopidogrel Bisulfate)?
7/17/2012
Plavix (clopidogrel disulfate) is a medication that prevents platelets from clumping together and forming blood clots. This prescription drug helps blood flow more easily, and reduces the chances of a future stroke or heart attack. Plavix is an oral, thienopyridine class antiplatelet agent. Antiplatelet agents decrease the accumulation of platelets, thus inhibiting thrombus (clot) formation...
Cancers are notorious for secreting chemicals that confuse the immune system and thwarting biological defenses. To counter that effect, some cancer treatments try to neutralize the cancer's chemical arsenal and boost a patient's immune response - though attempts to do both at the same time are rarely successful...
Obesity May Affect Response To Breast Cancer Treatment
7/16/2012
Experts have been questioning if hormone-suppressing drugs is the best treatment for obese women because they still have higher levels of estrogen than normal weight women even after treatment...
New Platinum Drug Kills Cancer Cells Better
7/16/2012
Researchers at Massachusetts Institute of Technology (MIT) in the US who are testing phenanthriplatin, a new experimental drug based on platinum, say it kills cancer cells better and may provide a more effective alternative to cisplatin, the most commonly used approved platinum chemotherapy drug...
For Patients With Acute Myeloid Leukemia, Mutation In Gene IDH A Possible Target For Treatment
7/16/2012
Many patients with acute myeloid leukemia (AML) share a mutation in a gene called IDH. A University of Colorado Cancer Center study published this week in the journal Leukemia & Lymphoma shows that this IDH mutation may be the first domino in a chain that leads to a more aggressive form of the disease...
Study Reveals Optimal Interval For Stomach Cancer Screening
7/16/2012
A new study has determined how often people should get screened for gastric or stomach cancer in high-risk regions of the world. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings could help reduce deaths from gastric cancer, which is the second most common cause of cancer-related mortality...
One Fifth Of Breast Conserving Surgeries Require Reoperation
7/15/2012
About one fifth of female breast cancer patients who chose breast conserving surgery instead of mastectomy eventually need another operation, British researchers reported in the BMJ (British Medical Journal)...
One Fifth Of Breast Conserving Surgeries Require Reoperation
7/14/2012
About one fifth of female breast cancer patients who chose breast conserving surgery instead of mastectomy eventually need another operation, British researchers reported in the BMJ (British Medical Journal)...
Managing Colorectal Cancer Using Multidrug Strategy
7/13/2012
A Harvard researcher studying the evolution of drug resistance in cancer says that, in a few decades, "many, many cancers could be manageable." "Many people are dying needlessly of cancer, and this research may offer a new strategy in that battle," said Martin Nowak, a professor of mathematics and of biology and director of the Program for Evolutionary Dynamics...